Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.36% | 145.38 | 0.6% | $1129.21m | |
| MRK | Merck & Co., Inc. | -2.12% | 76.71 | 0.6% | $1006.42m | |
| PFE | Pfizer Inc. | -2.35% | 43.93 | 0.9% | $997.18m | |
| ABBV | AbbVie, Inc. | -3.75% | 86.94 | 2.2% | $612.33m | |
| LLY | Eli Lilly and Company | -1.95% | 113.58 | 1.0% | $522.64m | |
| BMY | Bristol-Myers Squibb Company | -0.32% | 53.08 | 1.4% | $462.56m | |
| NVS | Novartis AG Sponsored ADR | -2.24% | 87.06 | 0.2% | $235.59m | |
| AZN | AstraZeneca PLC Sponsored ADR | -1.78% | 38.18 | 1.3% | $201.57m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | -0.37% | 37.28 | 0.2% | $135.92m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | -0.57% | 45.38 | 0.1% | $62.68m | |
| SNY | Sanofi Sponsored ADR | -0.55% | 43.47 | 0.2% | $42.50m | |
| LCI | Lannett Company, Inc. | -1.65% | 5.37 | 37.0% | $12.19m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | 1.11% | 1.82 | 1.7% | $0.03m | |
| EPIX | ESSA Pharma Inc | -13.07% | 2.30 | 0.1% | $0.00m |
Company Profile
Nightstar Therapeutics PLC is a clinical-stage gene therapy company, which engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. Its pipeline includes NSR-REP1, for the treatment of choroideremia; NSR-RPGR, for the treatment of X-linked retinitis pigmentosa; and NSR-BEST1, for the treatment of vitelliform macular dystrophy. The company was founded by Robert MacLaren on July 6, 2017 and is headquartered in London, the United Kingdom.